Pharming (PHAR) Other Accumulated Expenses (2019 - 2023)
Historic Other Accumulated Expenses for Pharming (PHAR) over the last 5 years, with Q3 2023 value amounting to -$10.9 million.
- Pharming's Other Accumulated Expenses fell 4510604.68% to -$10.9 million in Q3 2023 from the same period last year, while for Sep 2023 it was -$10.9 million, marking a year-over-year decrease of 4510604.68%. This contributed to the annual value of -$8.7 million for FY2022, which is 25707058.82% down from last year.
- According to the latest figures from Q3 2023, Pharming's Other Accumulated Expenses is -$10.9 million, which was down 4510604.68% from -$6.0 million recorded in Q2 2023.
- Pharming's Other Accumulated Expenses' 5-year high stood at $14.7 million during Q2 2021, with a 5-year trough of -$12.6 million in Q2 2022.
- In the last 5 years, Pharming's Other Accumulated Expenses had a median value of -$10976.0 in 2021 and averaged -$880584.2.
- Its Other Accumulated Expenses has fluctuated over the past 5 years, first plummeted by 39850535.25% in 2022, then skyrocketed by 5211.39% in 2023.
- Over the past 5 years, Pharming's Other Accumulated Expenses (Quarter) stood at $4.1 million in 2019, then crashed by 99.87% to $5175.7 in 2020, then crashed by 57.63% to $2193.0 in 2021, then plummeted by 398505.35% to -$8.7 million in 2022, then decreased by 24.93% to -$10.9 million in 2023.
- Its last three reported values are -$10.9 million in Q3 2023, -$6.0 million for Q2 2023, and -$8.7 million during Q4 2022.